Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALAI.L Regulatory News (ALAI)

  • There is currently no data for ALAI

Third Interim Dividend

24 Jun 2021 13:34

RNS Number : 0401D
Aberdeen Latin American Inc Fd Ltd
24 June 2021
 

Aberdeen Latin American Income Fund Limited (the "Company")

Legal Entity Identifier (LEI): 549300DN623WEGE2MY04

 

24 June 2021

 

Third Interim Dividend

The Board is pleased to declare a third interim dividend of 0.875 pence per Ordinary share (2020: 0.875p) in respect of the year ending 31 August 2021 payable on 30 July 2021 to Ordinary shareholders on the register at close of business on 9 July 2021 (ex-dividend date 8 July 2021).

The current level of dividend continues to be maintained, supplemented by revenue reserves, despite the weakening of Latin American currencies against sterling predominantly due to the impact of the Covid-19 pandemic and the continuing economic effects on the Company's equity investments, many of which have scaled back their distributions to conserve cash where possible through lockdowns. This has meant that the sterling income receipts of the Company have been reduced.

It is the Directors' current intention to utilise revenue reserves to maintain the payments at the same level for the year ending 31 August 2021.

If the volatility experienced in the region continues and currencies remain weak, the Directors believe that it is likely that the payment of a sustainable and covered dividend may necessitate a lower dividend payment in future years. The Directors continue to review closely the robustness of the Company's investments and its balance sheet and to monitor closely the impact of Covid-19 and associated vaccine rollouts, together with the ramifications for the region, valuations and recurring earnings, while balancing the income requirements of its shareholders, and will continue to keep its distribution policy under close review.

Aberdeen Standard Capital International Limited

Manager and Company Secretary

 

End

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVBDGDLXXDDGBS
Date   Source Headline
9th Nov 202212:26 pmRNSNet Asset Value(s)
8th Nov 202212:35 pmRNSNet Asset Value(s)
7th Nov 20222:56 pmRNSGearing disclosure
7th Nov 202212:28 pmRNSNet Asset Value(s)
4th Nov 20226:05 pmRNSMonth End Net Asset Value(s)
4th Nov 202212:51 pmRNSNet Asset Value(s)
3rd Nov 202212:42 pmRNSNet Asset Value(s)
2nd Nov 202212:38 pmRNSNet Asset Value(s)
31st Oct 20221:48 pmRNSGearing disclosure
31st Oct 202212:21 pmRNSNet Asset Value(s)
28th Oct 20221:13 pmRNSNet Asset Value(s)
27th Oct 202212:10 pmRNSNet Asset Value(s)
26th Oct 202212:40 pmRNSNet Asset Value(s)
25th Oct 202212:11 pmRNSNet Asset Value(s)
24th Oct 20224:05 pmRNSGearing Disclosure
24th Oct 20221:11 pmRNSNet Asset Value(s)
21st Oct 202212:53 pmRNSNet Asset Value(s)
20th Oct 20223:25 pmRNSNet Asset Value(s)
19th Oct 20225:56 pmRNSNet Asset Value(s)
18th Oct 20221:00 pmRNSNet Asset Value(s)
17th Oct 20223:45 pmRNSPortfolio Disclosure
17th Oct 20223:10 pmRNSGearing Disclosure
17th Oct 202212:32 pmRNSNet Asset Value(s)
17th Oct 202212:03 pmRNSGearing Disclosure
14th Oct 20221:28 pmRNSNet Asset Value(s)
13th Oct 20225:21 pmRNSHolding(s) in Company
13th Oct 202212:29 pmRNSNet Asset Value(s)
12th Oct 20221:30 pmRNSNet Asset Value(s)
11th Oct 202212:53 pmRNSNet Asset Value(s)
10th Oct 20224:35 pmRNSGearing Disclosure
10th Oct 20221:41 pmRNSNet Asset Value(s)
7th Oct 20221:00 pmRNSNet Asset Value(s)
7th Oct 202210:43 amRNSMonth End Net Asset Value(s)
6th Oct 202212:55 pmRNSNet Asset Value(s)
5th Oct 202212:53 pmRNSNet Asset Value(s)
4th Oct 202212:19 pmRNSNet Asset Value(s)
4th Oct 202211:01 amRNSGearing disclosure
3rd Oct 202211:07 amRNSCompliance with Market Abuse Regulation
30th Sep 20226:02 pmRNSHolding(s) in Company
30th Sep 20223:50 pmRNSHolding(s) in Company
30th Sep 202212:48 pmRNSNet Asset Value(s)
29th Sep 202212:33 pmRNSNet Asset Value(s)
28th Sep 202212:39 pmRNSNet Asset Value(s)
27th Sep 202212:56 pmRNSNet Asset Value(s)
26th Sep 20222:36 pmRNSGearing disclosure
26th Sep 20221:03 pmRNSNet Asset Value(s)
23rd Sep 202212:37 pmRNSNet Asset Value(s)
22nd Sep 202212:15 pmRNSNet Asset Value(s)
21st Sep 20221:52 pmRNSNet Asset Value(s)
20th Sep 20224:54 pmRNSGearing disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.